Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection

Bavaro, DF; Diella, L; Solimando, AG; Cicco, S; Buonamico, E; Stasi, C; Ciannarella, M; Marrone, M; Carpagnano, F; Resta, O; Carpagnano, GE; Palmieri, VO; Vacca, A; Dell'Aera, M; Dell'Erba, A; Migliore, G; Arico, M; Saracino, A

Diella, L (通讯作者)，Univ Bari, Clin Infect Dis, Piazza G Cesare 11, I-70124 Bari, Italy.

PATHOGENS AND GLOBAL HEALTH, 2022; 116 (5): 297

Abstract

The early administration of anti-SARS-CoV-2 monoclonal antibodies (mAb) could decrease the risk of severe disease and the need of inpatients care. Her......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索